386915008: Interferon alfa-2b (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with antiviral mechanism of action (substance)\Interferon\Interferon alfa (substance)\Interferon alfa-2b
\Substance categorized by disposition\Immunomodulator\Mediator of immune response and inflammation (substance)\Mediator of immune response (substance)\Cytokine\Cytokine agent (substance)\Interferon\Interferon alfa (substance)\Interferon alfa-2b
\Substance categorized by disposition\Immunomodulator\Immune enhancement agent\Interferon\Interferon alfa (substance)\Interferon alfa-2b

\Drug or medicament (substance)\Anti-infective agent (substance)\Substance with antiviral mechanism of action (substance)\Interferon\Interferon alfa (substance)\Interferon alfa-2b
\Drug or medicament (substance)\Immune enhancement agent\Interferon\Interferon alfa (substance)\Interferon alfa-2b
\Drug or medicament (substance)\Antineoplastic agent (substance)\Cytokine agent (substance)\Interferon\Interferon alfa (substance)\Interferon alfa-2b

\Substance categorised by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative\Substituted amide (substance)\Polypeptide\Protein\Glycoprotein (substance)\Cytokine\Cytokine agent (substance)\Interferon\Interferon alfa (substance)\Interferon alfa-2b

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative\Substituted amide (substance)\Polypeptide\Protein\Glycoprotein (substance)\Cytokine\Cytokine agent (substance)\Interferon\Interferon alfa (substance)\Interferon alfa-2b

\Biological substance\Protein and/or protein derivative\Protein\Glycoprotein (substance)\Cytokine\Cytokine agent (substance)\Interferon\Interferon alfa (substance)\Interferon alfa-2b
\Biological substance\Immunologic substance\Mediator of immune response and inflammation (substance)\Mediator of immune response (substance)\Cytokine\Cytokine agent (substance)\Interferon\Interferon alfa (substance)\Interferon alfa-2b
\Biological substance\Polypeptide\Protein\Glycoprotein (substance)\Cytokine\Cytokine agent (substance)\Interferon\Interferon alfa (substance)\Interferon alfa-2b

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Interferon alfa-2b	Is a	Immunologic substance	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b	Is a	classe d'allergènes	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b	Is a	allergène médicamenteux	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b	Is a	Immunomodulator	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b	Is a	Interferon	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b	Is a	Interferon alfa	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b	Is a	Interferon alfa (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b	Has disposition	Immunomodulator (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b	Has disposition	Antiviral (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing interferon alfa-2b (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Interferon-A-2b adverse reaction	Causative agent (attribute)	True	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Allergy to interferon alfa-2b (finding)	Causative agent (attribute)	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 10million iu powder and solvent for injection solution vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 5million iu powder and solvent for injection solution vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 3million iu injection (pdr for recon)+diluent (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 1million iu injection (pdr for recon)+diluent (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 6million iu/mL injection solution 3mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 15million iu/1mL prefilled pen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 25million iu/1mL prefilled pen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 50million iu/1mL prefilled pen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 25million iu/2.5mL injection solution (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Peginterferon alfa-2b	Is a	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 5000000unt/vial powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 25000000unt/vial powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 50000000unt/vial powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 10000000unt/vial powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 3000000unt/vial powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 18,000,000iu/vial powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 25 millioniu/vial solution (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 18 millioniu/vial solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 10 million iu/vial solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 3 million iu/vial solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 5 million iu/vial solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 30000000iu solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 60million/iu solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 150mcg powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 300mcg powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 120mcg powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 600mcg powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 100.000mcg powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 50mcg powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 10million iu/2mL injection solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Ribavirin+interferon alpha-2b	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Ribavirin 200mg capsule+interferon alpha-2b 3million iu/vial injection solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Allergy to interferon alfa-2b (finding)	Causative agent (attribute)	True	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing interferon alfa-2b in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Interferon alfa-2b 10million iu powder for injection solution vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 3million iu powder for injection solution vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 5million iu powder for injection solution vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Interferon alfa-2b 1 million unit powder for solution for injection vial	Has precise active ingredient	True	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Interferon alfa-2b 1 million unit powder for solution for injection vial	Has basis of strength substance (attribute)	True	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing interferon alfa-2b in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Interferon alfa-2b only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only interferon alfa-2b in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Interferon alfa-2b only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely interferon alfa-2b 10 million unit/1 milliliter conventional release solution for injection (clinical drug)	Has basis of strength substance (attribute)	True	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely interferon alfa-2b 10 million unit/1 milliliter conventional release solution for injection (clinical drug)	Has precise active ingredient	True	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Peginterferon alfa-2b	Is modification of (attribute)	True	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Has basis of strength substance (attribute)	True	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Interferon alfa-2b (as peginterferon alfa-2b) 100 microgram powder for solution for injection vial	Has basis of strength substance (attribute)	True	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Interferon alfa-2b (as peginterferon alfa-2b) 120 microgram powder for solution for injection vial	Has basis of strength substance (attribute)	True	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 80 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Has basis of strength substance (attribute)	True	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 150 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Has basis of strength substance (attribute)	True	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Interferon alfa-2b (as peginterferon alfa-2b) 120 microgram powder for solution for injection pen	Has basis of strength substance (attribute)	True	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 150 microgram/1 pen powder for conventional release solution for injection (clinical drug)	Has basis of strength substance (attribute)	True	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Interferon alfa-2b (as peginterferon alfa-2b) 50 microgram powder for solution for injection pen	Has basis of strength substance (attribute)	True	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Interferon alfa-2b (as peginterferon alfa-2b) 80 microgram powder for solution for injection pen	Has basis of strength substance (attribute)	True	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Ropeginterferon alfa-2b	Is modification of (attribute)	True	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely interferon alfa-2b (as ropeginterferon alfa-2b) 500 microgram/1 milliliter conventional release solution for injection (clinical drug)	Has basis of strength substance (attribute)	True	Interferon alfa-2b	Inferred relationship	Existential restriction modifier (core metadata concept)	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3005892013	Interferon alfa-2b	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3482325017	Interferon alfa-2b (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1461093017	Interferon alpha-2b preparation (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1481029017	Interferon alpha-2b preparation	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1763806019	Interferon alpha-2b (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1776044017	Interferon alpha-2b	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3005892013	Interferon alfa-2b	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3005892013	Interferon alfa-2b	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3005892013	Interferon alfa-2b	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3482325017	Interferon alfa-2b (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
56281000195114	interferone alfa 2b	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
71271000195117	Interferon alfa-2b	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
511000188114	interféron alfa-2b	fr	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
818061000172112	interféron alpha-2b	fr	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
511000188114	interféron alfa-2b	fr	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
818061000172112	interféron alpha-2b	fr	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
56281000195114	interferone alfa 2b	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
71271000195117	Interferon alfa-2b	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module